Ontrak, Inc. (OTRKP)
USD 0.25
(-9.42%)
USD 0.25
(-9.42%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -8.01 Million USD | -228.56% |
| 2022 | 6.23 Million USD | 129.16% |
| 2021 | -21.36 Million USD | 45.11% |
| 2020 | -38.93 Million USD | -289.22% |
| 2019 | 20.57 Million USD | 377.38% |
| 2018 | 4.31 Million USD | 190.22% |
| 2017 | -4.77 Million USD | -153.22% |
| 2016 | 8.97 Million USD | 219.2% |
| 2015 | 2.81 Million USD | 510.51% |
| 2014 | -685 Thousand USD | 38.29% |
| 2013 | -1.11 Million USD | 64.59% |
| 2012 | -3.13 Million USD | -306.61% |
| 2011 | -771 Thousand USD | -163.25% |
| 2010 | 1.21 Million USD | -76.08% |
| 2009 | 5.09 Million USD | 257.11% |
| 2008 | 1.42 Million USD | 135.51% |
| 2007 | -4.01 Million USD | 27.17% |
| 2006 | -5.51 Million USD | -61.49% |
| 2005 | -3.41 Million USD | 14.58% |
| 2004 | -4 Million USD | -16.14% |
| 2003 | -3.44 Million USD | -2228.83% |
| 2002 | 161.77 Thousand USD | 2260.8% |
| 2001 | -7487.00 USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -424 Thousand USD | 90.73% |
| 2024 Q1 | -4.57 Million USD | 42.92% |
| 2023 Q3 | 11.06 Million USD | 82.47% |
| 2023 Q2 | 6.06 Million USD | 126.31% |
| 2023 Q1 | 2.68 Million USD | -57.0% |
| 2023 FY | -8.01 Million USD | -228.56% |
| 2023 Q4 | -8.01 Million USD | -172.4% |
| 2022 Q4 | 6.23 Million USD | 86.64% |
| 2022 Q3 | 3.33 Million USD | 243.12% |
| 2022 Q2 | -2.33 Million USD | 75.37% |
| 2022 Q1 | -9.47 Million USD | 55.68% |
| 2022 FY | 6.23 Million USD | 129.16% |
| 2021 Q3 | -27.13 Million USD | 37.49% |
| 2021 Q2 | -43.39 Million USD | 2.14% |
| 2021 Q1 | -44.34 Million USD | -13.91% |
| 2021 FY | -21.36 Million USD | 45.11% |
| 2021 Q4 | -21.36 Million USD | 21.23% |
| 2020 Q4 | -38.93 Million USD | -303.16% |
| 2020 FY | -38.93 Million USD | -289.22% |
| 2020 Q1 | 23.71 Million USD | 15.25% |
| 2020 Q2 | 24.58 Million USD | 3.67% |
| 2020 Q3 | -9.65 Million USD | -139.28% |
| 2019 Q1 | 8.73 Million USD | 102.6% |
| 2019 Q4 | 20.57 Million USD | 25.1% |
| 2019 Q3 | 16.44 Million USD | 52.56% |
| 2019 FY | 20.57 Million USD | 377.38% |
| 2019 Q2 | 10.78 Million USD | 23.47% |
| 2018 FY | 4.31 Million USD | 190.22% |
| 2018 Q1 | -1.35 Million USD | 71.66% |
| 2018 Q2 | -738 Thousand USD | 45.49% |
| 2018 Q3 | 2.56 Million USD | 446.88% |
| 2018 Q4 | 4.31 Million USD | 68.36% |
| 2017 Q2 | -9.2 Million USD | -194.18% |
| 2017 FY | -4.77 Million USD | -153.22% |
| 2017 Q1 | 9.77 Million USD | 8.92% |
| 2017 Q4 | -4.77 Million USD | 30.97% |
| 2017 Q3 | -6.92 Million USD | 24.85% |
| 2016 Q3 | 6.84 Million USD | 12.03% |
| 2016 Q2 | 6.1 Million USD | 37.22% |
| 2016 FY | 8.97 Million USD | 219.2% |
| 2016 Q1 | 4.45 Million USD | 58.32% |
| 2016 Q4 | 8.97 Million USD | 31.15% |
| 2015 FY | 2.81 Million USD | 510.51% |
| 2015 Q4 | 2.81 Million USD | 56.22% |
| 2015 Q3 | 1.8 Million USD | -18.07% |
| 2015 Q2 | 2.19 Million USD | 1539.55% |
| 2015 Q1 | 134 Thousand USD | 119.56% |
| 2014 Q3 | -1.5 Million USD | -34.61% |
| 2014 Q4 | -685 Thousand USD | 54.61% |
| 2014 FY | -685 Thousand USD | 38.29% |
| 2014 Q1 | -699 Thousand USD | 37.03% |
| 2014 Q2 | -1.12 Million USD | -60.37% |
| 2013 Q3 | -404 Thousand USD | 74.81% |
| 2013 Q2 | -1.6 Million USD | -0.69% |
| 2013 Q1 | -1.59 Million USD | 49.19% |
| 2013 FY | -1.11 Million USD | 64.59% |
| 2013 Q4 | -1.11 Million USD | -174.75% |
| 2012 Q1 | 513 Thousand USD | 166.54% |
| 2012 FY | -3.13 Million USD | -306.61% |
| 2012 Q2 | -1.18 Million USD | -331.58% |
| 2012 Q3 | -1.47 Million USD | -24.16% |
| 2012 Q4 | -3.13 Million USD | -112.54% |
| 2011 Q1 | -2.59 Million USD | -312.8% |
| 2011 FY | -771 Thousand USD | -163.25% |
| 2011 Q2 | -632 Thousand USD | 75.64% |
| 2011 Q3 | 160 Thousand USD | 125.32% |
| 2011 Q4 | -771 Thousand USD | -581.88% |
| 2010 Q3 | -356 Thousand USD | -122.95% |
| 2010 Q2 | 1.55 Million USD | -79.57% |
| 2010 Q4 | 1.21 Million USD | 442.42% |
| 2010 FY | 1.21 Million USD | -76.08% |
| 2010 Q1 | 7.59 Million USD | 48.98% |
| 2009 Q2 | 8.07 Million USD | 74.02% |
| 2009 Q1 | 4.64 Million USD | 225.3% |
| 2009 Q4 | 5.09 Million USD | 98.67% |
| 2009 Q3 | 2.56 Million USD | -68.25% |
| 2009 FY | 5.09 Million USD | 257.11% |
| 2008 Q3 | -2.14 Million USD | -343.18% |
| 2008 Q4 | 1.42 Million USD | 166.68% |
| 2008 Q1 | -3.96 Million USD | 1.39% |
| 2008 FY | 1.42 Million USD | 135.51% |
| 2008 Q2 | 880 Thousand USD | 122.21% |
| 2007 Q1 | -3.18 Million USD | 42.28% |
| 2007 Q3 | -155 Thousand USD | 96.71% |
| 2007 Q2 | -4.7 Million USD | -47.72% |
| 2007 FY | -4.01 Million USD | 27.17% |
| 2007 Q4 | -4.01 Million USD | -2492.9% |
| 2006 Q3 | -3.65 Million USD | 9.8% |
| 2006 Q1 | -4.86 Million USD | -42.35% |
| 2006 Q4 | -5.51 Million USD | -51.01% |
| 2006 Q2 | -4.05 Million USD | 16.71% |
| 2006 FY | -5.51 Million USD | -61.49% |
| 2005 Q3 | -3.45 Million USD | -91.03% |
| 2005 Q4 | -3.41 Million USD | 0.96% |
| 2005 Q1 | -1.34 Million USD | 66.33% |
| 2005 FY | -3.41 Million USD | 14.58% |
| 2005 Q2 | -1.8 Million USD | -34.08% |
| 2004 Q1 | -1.67 Million USD | 51.51% |
| 2004 FY | -4 Million USD | -16.14% |
| 2004 Q4 | -4 Million USD | -272.44% |
| 2004 Q3 | -1.07 Million USD | -187.17% |
| 2004 Q2 | -374 Thousand USD | 77.6% |
| 2003 Q3 | -20.51 Million USD | 0.0% |
| 2003 Q4 | -3.44 Million USD | 83.21% |
| 2003 FY | -3.44 Million USD | -2228.83% |
| 2003 Q1 | 213.65 Thousand USD | 32.07% |
| 2002 Q4 | 161.77 Thousand USD | 0.0% |
| 2002 FY | 161.77 Thousand USD | 2260.8% |
| 2002 Q1 | 20.59 Thousand USD | 0.0% |
| 2001 FY | -7487.00 USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Inovalon Holdings, Inc. | 773.42 Million USD | 101.036% |
| GE HealthCare Technologies Inc. | 7.36 Billion USD | 100.109% |
| Sharecare, Inc. | -125.84 Million USD | 93.633% |
| Progyny, Inc. | -77.9 Million USD | 89.716% |
| Aclarion, Inc. | 94.65 Thousand USD | 8564.423% |
| CareMax, Inc. | 426.4 Million USD | 101.879% |
| Simulations Plus, Inc. | -9.83 Million USD | 18.544% |
| CareCloud, Inc. | 11.4 Million USD | 170.268% |
| Forian Inc. | 16.95 Million USD | 147.244% |
| Bullfrog AI Holdings, Inc. Warrants | -2.62 Million USD | -205.25% |
| Bullfrog AI Holdings, Inc. Common Stock | -2.62 Million USD | -205.25% |
| Minerva Surgical, Inc. | 32.74 Million USD | 124.466% |
| Omnicell, Inc. | 113.11 Million USD | 107.083% |
| Definitive Healthcare Corp. | 136.95 Million USD | 105.85% |
| Zhongchao Inc. | -6.74 Million USD | -18.863% |
| Accolade, Inc. | 55.93 Million USD | 114.325% |
| Streamline Health Solutions, Inc. | 7.37 Million USD | 208.623% |
| SOPHiA GENETICS SA | -104.65 Million USD | 92.344% |
| R1 RCM Inc. | 1.56 Billion USD | 100.511% |
| Spok Holdings, Inc. | -20.9 Million USD | 61.671% |
| Privia Health Group, Inc. | -381.22 Million USD | 97.898% |
| EUDA Health Holdings Limited | 3.18 Million USD | 351.513% |
| HeartBeam, Inc. | -16.18 Million USD | 50.51% |
| GeneDx Holdings Corp. | 20.08 Million USD | 139.883% |
| TruBridge, Inc. | 199.44 Million USD | 104.017% |
| Nutex Health, Inc. | 253.75 Million USD | 103.157% |
| Renalytix Plc | 3.85 Million USD | 307.834% |
| Sharecare, Inc. | -125.84 Million USD | 93.633% |
| Health Catalyst, Inc. | 142.79 Million USD | 105.611% |
| 10x Genomics, Inc. | -263.91 Million USD | 96.964% |
| GoodRx Holdings, Inc. | 38.77 Million USD | 120.663% |
| SCWorx Corp. | -1077.00 USD | -743818.292% |
| Schrödinger, Inc. | -33.18 Million USD | 75.856% |
| HealthEquity, Inc. | 529.16 Million USD | 101.514% |
| HealthStream, Inc. | -17.11 Million USD | 53.179% |
| MSP Recovery, Inc. | 667.69 Million USD | 101.2% |
| Augmedix, Inc. | -20.49 Million USD | 60.909% |
| BrightSpring Health Services, Inc. Common Stock | 3.65 Billion USD | 100.219% |
| Ontrak, Inc. | -8.01 Million USD | -0.0% |
| SHL Telemedicine Ltd. | 13.15 Million USD | 160.89% |
| CareCloud, Inc. | 11.4 Million USD | 170.268% |
| Premier, Inc. | 855 Thousand USD | 1037.076% |
| Certara, Inc. | 63.24 Million USD | 112.669% |
| GeneDx Holdings Corp. | 20.08 Million USD | 139.883% |
| OneMedNet Corporation | 5.05 Million USD | 258.518% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 3.65 Billion USD | 100.219% |
| EUDA Health Holdings Limited | 3.18 Million USD | 351.513% |
| HeartBeam, Inc. | -16.18 Million USD | 50.51% |
| CareCloud, Inc. | 11.4 Million USD | 170.268% |
| Mangoceuticals, Inc. | -610.32 Thousand USD | -1212.737% |
| CareMax, Inc. | 426.4 Million USD | 101.879% |
| Healthcare Triangle, Inc. | 3.08 Million USD | 359.877% |
| National Research Corporation | 32.3 Million USD | 124.803% |
| Aclarion, Inc. | 94.65 Thousand USD | 8564.423% |
| OptimizeRx Corporation | 22.97 Million USD | 134.878% |